Trademarkia Logo

Canada

C$
PERMANTIS
FORMALIZED

on 29 Apr 2024

Last Applicant/ Owned by

PERMANTIS LLC

809 Laurel St #70San Carlos, CA 94070

US

Serial Number

2324314 filed on 29th Apr 2024

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

PERMANTIS

Trademark usage description

diagnostics for clinical and scientific research purposes; diagnostic tools, diagnostic preparations, biologics and therapeutics for clinical and scie Read More

Classification Information


Class [001]
Diagnostics for clinical and scientific research purposes; diagnostic tools, diagnostic preparations, biologics and therapeutics for clinical and scientific research purposes, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic tests used for providing clinical scientific laboratory services according to the Clinical Laboratory Improvement Amendments (CLIA) program, namely, for the detection of diseases, disorders and conditions


Classification kind code

12

Class [005]
Diagnostics, biologics and therapeutics for medical use, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic kits for medical use, namely, the detection of diseases, disorders and conditions; pharmaceutical preparations for medical use, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic tests used for providing medical testing services according to the Clinical Laboratory Improvement Amendments (CLIA) program, namely, for the detection of diseases, disorders and conditions


Classification kind code

12

Class [035]
Promoting technical and scientific investigation, research and experimentation in the field of genomics; promoting technical and scientific investigation, research and experimentation in the field of patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of diseases, disorders and conditions


Classification kind code

12

Class [036]
Financial asset and investment management services; financial services, namely, private equity investments and funding in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; investment services, namely, investing in technologies focused on the detection, disruption, prevention and treatment of diseases, disorders and conditions; financial services, namely, business fundraising for others; fundraising to support scientific and medical research and procedures; capital investment services


Classification kind code

12

Class [042]
Biological and pharmaceutical research and development; medical and scientific research; scientific and medical research and consulting in the field of genomics; scientific and medical research and consulting focused on the detection, disruption, prevention and treatment of diseases, disorders and conditions; technical scientific research and medical research services focused on patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of diseases, disorders and conditions; research, design, development and testing of diagnostics, biologics and therapeutics for the detection, disruption, prevention and treatment of diseases, disorders and conditions; providing laboratory research services in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; providing medical and scientific research information in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; compilation of biological and statistical data for research purposes in the fields of medical and scientific research; providing clinical scientific laboratory services for others according to the Clinical Laboratory Improvement Amendments (CLIA) program; CLIA-based medical testing for diagnostic purposes; providing nucleic acid sequencing and analysis services under CLIA certification standards; providing diagnostic services under CLIA certification standards, namely, collecting patient samples, processing and analyzing patient samples, and delivering results of the processing and analysis, all carried out in a CLIA-certified laboratory


Classification kind code

12

Class [044]
Medical and veterinary, beauty, agricultural and forestry


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [045]
Licensing of intellectual property rights


Classification kind code

12

Mark Details


Serial Number

2324314

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 67
on 27th Sept 2024
Agent Name Changed
Submitted for opposition 287
on 9th May 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 29th Apr 2024
Filed
Submitted for opposition 1
on 29th Apr 2024
Created
Submitted for opposition 31
on 29th Apr 2024
Formalized